CAR-T Cell Therapy
Treatment using genetically modified T cells expressing a chimeric antigen receptor. Approved for B-cell lymphomas, ALL, and multiple myeloma; emerging for solid tumors.
7 Treatments
CAR-T Cell Therapy
ViewCAR-T Cell Therapy for Autoimmune Disorders
ViewCAR-T Cell Therapy for Leukemia
ViewCAR-T Cell Therapy for Liver Cancer
ViewCAR-T Cell Therapy for Solid Tumors
ViewCAR-T Cell Therapy in China: Patient Guide to Access and Outcomes
ViewCAR T Cell Therapy in India: A Clear Guide to Cost, Hospitals, and Who It Can Help
View